(E)-1-(4-Decyloxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one

In the title compound, C25H32O3, the asymmetric unit contains two crystallographically independent molecules: both enone groups adopt an s-cis configuration. In the crystal, O—H⋯O and C—H⋯O intermolecular interactions form bifurcated hydrogen bonds, which generate R 1 2(6) ring motifs. These intermolecular interactions link the molecules into one-dimensional chains along the [10] direction. The crystal structure is further stabilized by C—H⋯π interactions.

[1]  M. Küçük,et al.  Synthesis and Biological Activities of N -Alkyl Derivatives of o-, m -, and p-Nitro (E )-4-Azachalcones and Stereoselective Photochemistry in Solution, with Theoretical Calculations , 2006 .

[2]  A. M. Glazer,et al.  A nitrogen‐gas‐stream cryostat for general X‐ray diffraction studies , 1986 .

[3]  G. Sheldrick.  A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.

[4]  B T Fan,et al.  3D QSAR studies on antimalarial alkoxylated and hydroxylated chalcones by CoMFA and CoMSIA. , 2004, European journal of medicinal chemistry.

[5]  Zhe-shan Quan,et al.  Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives. , 2005, Bioorganic & medicinal chemistry letters.

[6]  Anthony L. Spek,et al.  Structure validation in chemical crystallography , 2009, Acta crystallographica. Section D, Biological crystallography.

[7]  A. Saxena,et al.  Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents. , 2005, Bioorganic & medicinal chemistry letters.

[8]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[9]  Olga Kennard,et al.  Tables of bond lengths determined by X-ray and neutron diffraction. Part 1. Bond lengths in organic compounds , 1987 .

[10]  P. S. Patil,et al.  3-(4-Bromo­phen­yl)-1-(4-chloro­phenyl)prop-2-en-1-one , 2006 .

[11]  R. Pratap,et al.  Synthesis and antihyperglycemic activity of chalcone based aryloxypropanolamines. , 2004, Bioorganic & medicinal chemistry.

[12]  Raymond E. Davis,et al.  Patterns in Hydrogen Bonding: Functionality and Graph Set Analysis in Crystals , 1995 .

[13]  Tricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1). , 2002, Bioorganic & medicinal chemistry letters.